FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Kimvent Q2 Oral Care Kit Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
- Swelling, rash, or fever develop.
- Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting occurs.
- Do not use more than 2 days or administer to children under 3 years of age unless directed by a physician.
Keep out of reach of children under 3 years of age.
- Swelling, rash, or fever develop.
- Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting occurs.
- Do not use more than 2 days or administer to children under 3 years of age unless directed by a physician.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
- Aids in the removal of phlegm, mucus, or other secretions in the temporary relief of discomfort due to occasional sore throat and sore mouth.
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Kimvent Q2 Oral Care Kit Manufacturers
- Halyard Health
Kimvent Q2 Oral Care Kit | Halyard Health
Topical dosage for adults and children 3 years of age and older is a rinse used no more than 4 times daily. For children under 3 years of age, there is no recommended dosage except under the advice and supervision of a dentist or doctor. Use only under health care practitioners supervision. - Kimberly-clark Corporation
Kimvent Q2 Oral Care Kit | Avkare, Inc.
Dosage depends on the severity of the disease and the response of the patient. Patients should be continually monitored for signs that indicate dosage adjustment is necessary, such as remission or exacerbations of the disease and stress (surgery, infection, trauma)(see WARNINGS and PRECAUTIONS, General).
Addison's DiseaseIn Addison's disease, the combination of fludrocortisone acetate tablets with a glucocorticoid such as hydrocortisone or cortisone provides substitution therapy approximating normal adrenal activity with minimal risks of unwanted effects.
The usual dose is 0.1 mg of fludrocortisone acetate tablets daily, although dosage ranging from 0.1 mg three times a week to 0.2 mg daily has been employed. In the event transient hypertension develops as a consequence of therapy, the dose should be reduced to 0.05 mg daily. Fludrocortisone acetate tablets are preferably administered in conjunction with cortisone (10 mg to 37.5 mg daily in divided doses) or hydrocortisone (10 mg to 30 mg daily in divided doses).
Salt-Losing Adrenogenital SyndromeThe recommended dosage for treating the salt-losing adrenogenital syndrome is 0.1 mg to 0.2 mg of fludrocortisone acetate tablets daily.
Login To Your Free Account